ruxolitinib
novartis,incyte
['ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)']
#ash22 update: new data confirm that ruxolitinib reduces the risk of thrombosis and improves efs compared with the bat for patients with high-risk polycythemia vera (pv) who were resistant or intolerant to hydroxycarbamide. #medtwitter #medonc 
OBR is an oncology-focused digital media company that provides news and information resources to oncology professionals.